__NUXT_JSONP__("/drugs/Nemorubicin_Hydrochloride", (function(a,b,c){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"108943-08-4",chebiId:"",chemicalFormula:"C32H37NO13.HCl",definition:"The hydrochloride salt form of nemorubicin, a morpholinyl analogue of the anthracycline doxorubicin with antineoplastic activity. Nemorubicin is metabolized via the P450 CYP3A enzyme to a highly cytotoxic derivative. Unlike most anthracyclines, nemorubicin is a topoisomerase I inhibitor and appears to exert its effect through the nucleotide excision repair (NER) system. In addition, this agent does not show cross-resistance with other anthracyclines.",fdaUniiCode:"2Q6F8JYX76",identifier:"C84000",preferredName:b,semanticType:"Pharmacologic Substance",subclassOf:["C1594"],synonyms:["5,12-Naphthacenedione, 7,8,9,10-Tetrahydro-6,8,11-Trihydroxy-8-(Hydroxyacetyl)-1-Methoxy-10-((2,3,6-Trideoxy-3-((2S)-2-Methoxy-4-Morpholinyl)-Alpha-L-Lyxo-Hexopyranosyl)Oxy)-, Hydrochloride, (8S,10S)-","NEMORUBICIN HYDROCHLORIDE",b]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FNemorubicin_Hydrochloride",extension:".json",createdAt:c,updatedAt:c}}],fetch:{},mutations:void 0}}("Nemorubicin_Hydrochloride","Nemorubicin Hydrochloride","2021-10-30T13:46:14.433Z")));